These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28710382)

  • 41. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.
    Tu M; Cai L; Zheng W; Su Z; Chen Y; Qi S
    Mol Med Rep; 2017 Apr; 15(4):1713-1721. PubMed ID: 28259931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
    Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
    Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AnnexinA5 promote glioma cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway.
    Ji C; Guo H; Zhang P; Kuang W; Fan Y; Wu L
    J Neurooncol; 2018 Jul; 138(3):469-478. PubMed ID: 29520611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
    Song L; Liu L; Wu Z; Li Y; Ying Z; Lin C; Wu J; Hu B; Cheng SY; Li M; Li J
    J Clin Invest; 2012 Oct; 122(10):3563-78. PubMed ID: 23006329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NF-kappaB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors.
    Paradisi A; Maisse C; Bernet A; Coissieux MM; Maccarrone M; Scoazec JY; Mehlen P
    Gastroenterology; 2008 Oct; 135(4):1248-57. PubMed ID: 18692059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
    PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.
    Cheng CY; Chou YE; Ko CP; Yang SF; Hsieh SC; Lin CL; Hsieh YH; Chen KC
    J Neurooncol; 2014 Nov; 120(2):273-81. PubMed ID: 25048531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation.
    Lei Q; Gu H; Li L; Wu T; Xie W; Li M; Zhao N
    J Cell Mol Med; 2020 Jan; 24(1):530-538. PubMed ID: 31691497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.
    Tung JN; Ko CP; Yang SF; Cheng CW; Chen PN; Chang CY; Lin CL; Yang TF; Hsieh YH; Chen KC
    J Neurooncol; 2016 Sep; 129(2):201-9. PubMed ID: 27278519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.
    Miao F; Cui C; Zuo D; Zhang H; Mei P; Chen H; Wei S; Yang F; Zheng J; Bai J; Fan Y
    J Neurooncol; 2019 Jun; 143(2):221-229. PubMed ID: 30997639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
    Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
    Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
    Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W
    Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
    Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
    Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.
    Li X; Liu D; Liu X; Jiang W; Zhou W; Yan W; Cen Y; Li B; Cao G; Ding G; Pang X; Sun J; Zheng J; Zhou H
    Tumour Biol; 2012 Oct; 33(5):1607-18. PubMed ID: 22739939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.
    Edwards LA; Woolard K; Son MJ; Li A; Lee J; Ene C; Mantey SA; Maric D; Song H; Belova G; Jensen RT; Zhang W; Fine HA
    J Natl Cancer Inst; 2011 Aug; 103(15):1162-78. PubMed ID: 21771732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
    Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
    Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of Hsc70 promotes proliferation, migration, and invasion of human glioma cells.
    Sun G; Cao Y; Xu Y; Huai D; Chen P; Guo J; Li M; Dai Y
    J Cell Biochem; 2019 Jun; 120(6):10707-10714. PubMed ID: 30816582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of LN-308 glioma cell proliferation and migration by retinoic acid amide through activation of Akt pathway.
    Zhu J; Lu XD; Si F; Song CY; Meng QH
    Int J Clin Exp Pathol; 2015; 8(11):13921-7. PubMed ID: 26823704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.